Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index

Metabolism: Clinical and Experimental

Volumn 58, Issue 6, 2009, Pages 860-866

  Ruge, Toralph ^a   Lockton, J Andrew ^b   Renstrom, Frida ^a   Lystig, Theodore ^c   Sukonina, Valentina ^a   Svensson, Maria K ^d   Eriksson, Jan W ^c,d  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; METFORMIN; REPAGLINIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISOLATION PROCEDURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOKINES; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERINSULINISM; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65549113825     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.02.010     Document Type: Article

References (32)

1. Febbraio M.A., and Pedersen B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16 (2002) 1335-1347
2. Hotamisligil G.S. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245 (1999) 621-625
3. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 116 (2006) 1793-1801
4. Tataranni P.A., and Ortega E. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?. Diabetes 54 (2005) 917-927
5. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
6. Starkie R.L., Arkinstall M.J., Koukoulas I., Hawley J.A., and Febbraio M.A. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 533 (2001) 585-591
7. Fasshauer M., Klein J., Lossner U., and Paschke R. Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm Metab Res 35 (2003) 147-152
8. Carey A.L., Bruce C.R., Sacchetti M., Anderson M.J., Olsen D.B., Saltin B., et al. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 47 (2004) 1029-1037
9. Krogh-Madsen R., Moller K., Dela F., Kronborg G., Jauffred S., and Pedersen B.K. Effect of hyperglycemia and hyperinsulinaemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 286 (2004) E766-E772
10. Krogh-Madsen R., Plomgaard P., Keller P., Keller C., and Pedersen B.K. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue. Am J Physiol Endocrinol Metab 286 (2004) E234-E238
11. Cartier A., Lemieux I., Alméras N., Tremblay A., Bergeron J., and Després J.P. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interlukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab 93 (2008) 1931-1938
12. Borst S.E. The role of TNF-alpha in insulin resistance. Endocrine 23 (2004) 177-182
13. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996) 665-668
14. Havel P.J. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53 Suppl 1 (2004) S143-S151
15. Jequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 967 (2002) 379-388
16. Faraj M., Beauregard G., Loizon E., Moldes M., Clement K., Tahiri Y., et al. Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: relation to adiponutrin. J Endocrinol 191 (2006) 427-435
17. Kolaczynski J.W., Nyce M.R., Considine R.V., Boden G., Nolan J.J., Henry R., et al. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 45 (1996) 699-701
18. Lewandowski K., Randeva H.S., O'Callaghan C.J., Horn R., Medley G.F., Hillhouse E.W., et al. Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin. Clin Endocrinol (Oxf) 54 (2001) 533-539
19. Mohlig M., Wegewitz U., Osterhoff M., Isken F., Ristow M., Pfeiffer A.F., et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res 34 (2002) 655-658
20. Smith U., Sjostrom L., and Bjorntorp P. Comparison of two methods for determining human adipose cell size. J Lipid Res 13 (1972) 822-824
21. Buren J., Liu H.X., Jensen J., and Eriksson J.W. Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur J Endocrinol 146 (2002) 419-429
22. Holm C., Olivecrona G., and Ottosson M. Assays of lipolytic enzymes. Methods Mol Biol 155 (2001) 97-119
23. Wang B., Jenkins J.R., and Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab 288 (2005) E731-E740
24. Zeger S.L., and Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130
25. Rotnitzky A., and Jewell N.P. Hypothesis testing of regression parameters in semi-parametric generalized linear-models for cluster correlated data. Biometrika 77 (1990) 485-497
26. Mallows C. Some comments on C-P. Technometrics 42 (2000) 87-94
27. Pedersen B.K., Steensberg A., and Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol 536 (2001) 329-337
28. Esteve E., Villuendas G., Mallolas J., Vendrell J., Lopez-Bermejo A., Rodriguez M., et al. Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin Endocrinol (Oxf) 65 (2006) 88-91
29. Carey A.L., Lamont B., Andrikopoulos S., Koukoulas I., Proietto J., and Febbraio M.A. Interleukin-6 gene expression is increased in insulin-resistant rat skeletal muscle following insulin stimulation. Biochem Biophys Res Commun 302 (2003) 837-840
30. Bauer J., Hohagen F., Ebert T., Timmer J., Ganter U., Krieger S., et al. Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. The Clinical investigator 72 (1994) 315
31. Sothern R.B., Roitman-Johnson B., Kanabrocki E.L., Yager J.G., Fuerstenberg R.K., Weatherbee J.A., et al. Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. In vivo (Athens, Greece) 9 (1995) 331-339
32. Vgontzas A.N., Bixler E.O., Lin H.M., Prolo P., Trakada G., and Chrousos G.P. IL-6 and its circadian secretion in humans. Neuroimmunomodulation 12 (2005) 131-140